These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 21726494

  • 21. [Two new antidepressants: mirtazapine and venlafaxine].
    Birkenhäger TK, Moleman P.
    Ned Tijdschr Geneeskd; 1999 May 01; 143(18):934-7. PubMed ID: 10368708
    [Abstract] [Full Text] [Related]

  • 22. Hyponatremia with venlafaxine.
    Masood GR, Karki SD, Patterson WR.
    Ann Pharmacother; 1998 Jan 01; 32(1):49-51. PubMed ID: 9475820
    [Abstract] [Full Text] [Related]

  • 23. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun 01; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

  • 24. Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
    Benedict A, Arellano J, De Cock E, Baird J.
    J Affect Disord; 2010 Jan 01; 120(1-3):94-104. PubMed ID: 19497623
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA, Hanwella R.
    Int Clin Psychopharmacol; 2012 Jan 01; 27(1):8-16. PubMed ID: 21971532
    [Abstract] [Full Text] [Related]

  • 26. Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
    Seo HJ, Jung YE, Woo YS, Jun TY, Chae JH, Bahk WM.
    Hum Psychopharmacol; 2009 Mar 01; 24(2):135-43. PubMed ID: 19156709
    [Abstract] [Full Text] [Related]

  • 27. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Masand PS, Gupta S.
    Ann Clin Psychiatry; 2002 Sep 01; 14(3):175-82. PubMed ID: 12585567
    [Abstract] [Full Text] [Related]

  • 28. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr 01; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 29.
    Sobieraj DM, Baker WL, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC.
    ; 2019 03 01. PubMed ID: 30964616
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM.
    Clin Ther; 2002 Jul 01; 24(7):1194-200. PubMed ID: 12182262
    [Abstract] [Full Text] [Related]

  • 31. Mirtazapine-induced hyponatremia in an elderly hospice patient.
    Ladino M, Guardiola VD, Paniagua M.
    J Palliat Med; 2006 Apr 01; 9(2):258-60. PubMed ID: 16629552
    [Abstract] [Full Text] [Related]

  • 32. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug 01; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 33. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.
    Cochrane Database Syst Rev; 2015 May 01; 2015(5):CD011681. PubMed ID: 25931277
    [Abstract] [Full Text] [Related]

  • 34. Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies.
    Nagashima T, Hayakawa T, Akimoto H, Minagawa K, Takahashi Y, Asai S.
    Clin Pharmacol Ther; 2022 Jun 01; 111(6):1258-1267. PubMed ID: 35258103
    [Abstract] [Full Text] [Related]

  • 35. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME.
    Biol Psychiatry; 2008 Feb 15; 63(4):424-34. PubMed ID: 17888885
    [Abstract] [Full Text] [Related]

  • 36. Weight gain and associated factors in patients using newer antidepressant drugs.
    Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R.
    Gen Hosp Psychiatry; 2015 Feb 15; 37(1):46-8. PubMed ID: 25467076
    [Abstract] [Full Text] [Related]

  • 37. Mirtazapine-associated hyponatremia presenting as delirium.
    Ghosh A, Hegde A, Grover S.
    Indian J Pharmacol; 2014 Feb 15; 46(4):448-9. PubMed ID: 25097290
    [Abstract] [Full Text] [Related]

  • 38. SIADH with multiple antidepressants in a geriatric patient.
    Blass DM, Pearson VE.
    J Clin Psychiatry; 2000 Jun 15; 61(6):448-9. PubMed ID: 10901346
    [No Abstract] [Full Text] [Related]

  • 39. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Jun 15; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 40. Comment: hyponatremia with venlafaxine.
    Boyd IW.
    Ann Pharmacother; 1998 Sep 15; 32(9):981-2. PubMed ID: 9762390
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.